Yang F, Gao R, Luo X, Liu R, Xiong D
Ketogenic diets and protective mechanisms in epilepsy, metabolic disorders, cancer, neuronal loss, and muscle and nerve degeneration
It was unknown whether semaglutide would mitigate the high risk of kidney failure, CV events and death, in patients with type 2 diabetes and CKD, researchers led by UNSW Sydney, wrote in The New England Journal of Medicine
GLP-1 activation alone produces meaningful weight loss, as demonstrated by Semaglutide achieving approximately 15% reduction in clinical trials
Front Endocrinol 13:1092837 Omon EA, Ajayi OD (2023) Oxidative stress and antioxidants markers in individuals with thyroid hormones dysfunction